Phase 1 × Unknown × Leukemia, Lymphocytic, Chronic, B-Cell × Clear all First in Human Study of NVG-111 in Relapsed/Refractory ROR1+ Malignancies
Phase 1 Unknown
90 enrolled
A Phase I Study of LP-108 in Patients With Relapsed or Refractory B-cell Lymphoma
Phase 1 Unknown
74 enrolled
Anti-CD19 CAR-Engineered NK Cells in the Treatment of Relapsed/Refractory B-cell Malignancies
Phase 1 Unknown
15 enrolled
PSB202 in Patients With Previously Treated-, Relapsed-, Indolent B-Cell Malignancies
Phase 1 Unknown
110 enrolled
BET2017
Phase 1 Unknown
19 enrolled
Vaccine Therapy for Treating Patients With Previously Untreated Chronic Lymphocytic Leukemia (CLL)
Phase 1 Unknown
30 enrolled
Cord Blood Derived Anti-CD19 CAR-Engineered NK Cells for B Lymphoid Malignancies
Phase 1 Unknown
27 enrolled
Clinical Study of CAR-iNKT Cells in the Treatment of Relapsed/Refractory/High-risk B-cell Tumors
Phase 1 Unknown
20 enrolled
Universal Chimeric Antigen Receptor-modified AT19 Cells for CD19+ Relapsed/Refractory Hematological Malignancies
Phase 1 Unknown
27 enrolled
NK Cells in Cord Blood Transplantation
Phase 1 Unknown
13 enrolled
Anti-CD19 CAR T Infusion Combined With Allogeneic Stem Cell Transplantation for B-cell Leukemia/Lymphoma
Phase 1 Unknown
20 enrolled
Safety, Tolerability, and Pharmacokinetics of SHC014748M in Patients With Indolent B-Cell Hematologic Malignancies
Phase 1 Unknown
40 enrolled
A Phase I Study of YY-20394 in Patients With B Cell Hematologic Malignancies
Phase 1 Unknown
42 enrolled
CART19 Cells Treatment of MRD of B Cell Malignancies and Then Auto-HSCT
Phase 1 Unknown
20 enrolled
Emergency Use of Donor Lymphocytes in Treating Patients Who Have Undergone Donor Stem Cell Transplant and Have Cytomegalovirus Infections
Phase 1 Unknown
20 enrolled
Monoclonal Antibody Therapy in Treating Patients With Recurrent Acute Lymphoblastic Leukemia or Non-Hodgkin's Lymphoma
Phase 1 Unknown
Monoclonal Antibody Therapy, Paclitaxel, and Cyclosporine in Treating Patients With Recurrent or Refractory Non-Hodgkin's Lymphoma
Phase 1 Unknown
Carbendazim in Treating Patients With Advanced Solid Tumors or Lymphoma
Phase 1 Unknown
AMG 706 and Gemcitabine in Treating Patients With Advanced Solid Tumors or Lymphoma
Phase 1 Unknown
18 enrolled
Monoclonal Antibody Therapy, Chemotherapy, and Peripheral Stem Cell Transplantation in Treating Patients With Refractory Non-Hodgkin's Lymphoma
Phase 1 Unknown
Radiolabeled Monoclonal Antibody, Combination Chemotherapy, and Peripheral Stem Cell Transplantation in Treating Patients With Recurrent or Refractory B-Cell Cancer
Phase 1 Unknown
Safety and Efficacy Study of Iodine-131 Anti-B1 Antibody for Chronic Lymphocytic Leukemia
Phase 1 Unknown
30 enrolled